![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://ars.els-cdn.com/content/image/1-s2.0-S2211383522002696-gr2.jpg)
![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://www.sdu.dk/-/media/fl/hjemmeside-2024/skaermbillede-2025-01-21-kl,-d-,-14,-d-,37,-d-,51.png?la=en&hash=188A7075C3BD97C7640B6FC31092F21B)
![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639d/10230051/9f6352454904/fimmu-14-1148209-g010.jpg)
![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://www.frontiersin.org/files/Articles/1610368/xml-images/fimmu-16-1610368-g001.webp)
glp-1 inflammation
Shipping Estimate
glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+
USD20.35
USD55.35
Pay in 4 interest-free payments of $5.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugsTherapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://moonlight-paper-snapshot.s3.ap-northeast-2.amazonaws.com/arxiv/reduced-intestinal-glp-1-cell-numbers-are-associated-with-an-inflammation-related-epithelial-metabolic-signature-1.png)
![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugsTherapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://ars.els-cdn.com/content/image/1-s2.0-S1043661822002651-gr1.jpg)
![glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugsTherapeutic potential exploration in lung injury Literature Review] Reduced intestinal GLP-1+](https://www.frontiersin.org/files/Articles/1612034/xml-images/fmed-12-1612034-g002.webp)
